NGM Biopharmaceuticals rises on potential go-private deal
** Shares of NGM Biopharmaceuticals NGM.O rise 21.1% to
$1.04 premarket
** Late on Friday, NGM said its board is exploring a
potential buyout of all shares not owned by the company
** NGM will go private if a deal goes through
** 4 of 6 brokerages rate the stock "buy" or higher, 2
"hold"; their median PT is $4
** NGM stock stayed flat in 2023
(Reporting by Puyaan Singh)
((Puyaan.Singh@thomsonreuters.com;))
Recent news on NGM Biopharmaceuticals
See all newsBrief: NGM Biopharmaceuticals Q4 Net Income USD -27.67 Million
Brief: NGM Bio Enters into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group
NGM Biopharmaceuticals Inc expected to post a loss of 39 cents a share - Earnings Preview
Brief: Ngm Biopharmaceuticals Says It Got Written Notice From Nasdaq Informing It Has Regained Compliance With Nasdaq Listing
Brief: NGM Bio Announces New Clinical Data From Ongoing Trial Of Ngm707 In Advanced Solid Tumors